East Hanover, NJ, February 14, 2022. A team of researchers published results of a study of the Symbol Digit Modalities Test (SDMT), a measure widely used for cognitive assessment in research and ...
Treatment with ozanimod (Zeposia) led to clinically meaningful improvement in cognitive processing speed among people with early relapsing multiple sclerosis (RMS), an ad hoc interim analysis of the ...
All tests were administered in a standardized individual setting during the routine clinical process. Patients were initially tested with the screening tool, i.e. the short version of the BRB, [12] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback